Colorectal cancer (CRC) is one of the most prevalent cancer types worldwide, with a high
mortality rate due to metastasis. The tumor microenvironment (TME) contains multiple …

Rationale: Platelets can influence the progression and prognosis of colorectal cancer (CRC)
through multiple mechanisms, including crosstalk with tumor-associated macrophages …

Ctenopharyngodon idella and Squaliobarbus curriculus, members of the Cyprinidae family
and Yaroideae subfamily, have shown different levels of resistance to grass carp reo virus …

Background The therapeutic targeting of the tumor microenvironment (TME) in colorectal
cancer (CRC) has not yet been fully developed and utilized because of the complexity of the …

Immune checkpoint blockade (ICB) therapies induce durable responses in approximately
15% of colorectal cancer (CRC) patients who exhibit microsatellite instability-high (MSI-H) or …

Lipid-coated perfluorocarbon nanodroplets (lp-NDs) hold great promise in bio-medicine as
vehicles for drug delivery, molecular imaging and vaccine agents. However, their clinical …

Background Colorectal cancer (CRC) is a prevalent malignancy of the gastrointestinal.
Circular RNAs (circRNAs) act as important roles in CRC malignant progression. However …

Liver cancer is the sixth most common cancer and the fourth most fatal cancer in the world.
Immunotherapy has already achieved modest results in the treatment of liver cancer …

Rituximab has been incorporated into the standard treatment regimen for diffuse large B-cell
lymphoma (DLBCL), and induces the death of tumor cells via complement-dependent …

Cuproptosis is a recently discovered type of programmed cell death that shows significant
potential in the diagnosis and treatment of cancer. It has important significance in the …